The Case for Prevention

The Importance of Screening

Early detection is the single most effective way to improve outcomes across a wide range of conditions. Screening allows us to identify problems before symptoms appear.

Endocrine Disorders

The endocrine system produces hormones that regulate metabolism, growth, reproduction, and mood. Disorders of this system are common and often develop gradually, making them easy to miss without screening.

Thyroid disorders affect approximately 1 in 20 people in the UK. Hypothyroidism (underactive thyroid) causes fatigue, weight gain, and depression, while hyperthyroidism (overactive thyroid) can lead to anxiety, weight loss, and heart palpitations. Both conditions are readily treatable once identified.

Diabetes affects over 4.9 million people in the United Kingdom, with an estimated 1 million undiagnosed cases. Type 2 diabetes often develops silently over years. Screening with fasting glucose and HbA1c (a 3-month glucose marker) can detect pre-diabetes and diabetes early, allowing lifestyle changes and treatment to prevent complications including heart disease, kidney damage, and vision loss.

Vitamin D deficiency is widespread in the UK due to limited sunlight, affecting bone health, immune function, and mood. Our comprehensive blood panel includes vitamin D, calcium, and phosphate to assess bone metabolism alongside thyroid function, iron studies, and nutrition markers.

Cardiac Screening

Atrial Fibrillation

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting over 1.4 million people in the UK. It increases the risk of stroke fivefold. Many people with AF have no symptoms, and the condition is often discovered incidentally during a routine ECG or health check.

Early detection of AF allows for appropriate anticoagulation therapy, dramatically reducing stroke risk. Our screening packages include cardiovascular assessment, and the Burlington and Knightsbridge packages include CT coronary arteries for detailed imaging of the heart.

Coronary Heart Disease

Coronary heart disease (CHD) remains the single largest cause of death in the United Kingdom. According to the British Heart Foundation, there are around 68,000 deaths from CHD each year in the UK, and approximately 2.3 million people are living with the condition.

Many of the risk factors for CHD are modifiable: high cholesterol, high blood pressure, smoking, diabetes, and physical inactivity. A comprehensive health screening can identify these risk factors years before they cause symptoms. Our cholesterol profile, glucose markers, and optional CT coronary artery imaging provide a detailed picture of cardiovascular health.

The British Heart Foundation emphasises that early identification and management of risk factors can significantly reduce the likelihood of heart attack and stroke. Regular screening is particularly important for those with a family history of heart disease.

Lung Cancer Screening

Lung cancer is the third most common cancer in the UK, with approximately 49,200 new cases diagnosed each year. It is also the leading cause of cancer death. The reason for this high mortality is late diagnosis: around 75% of lung cancers are diagnosed at stage III or IV, when treatment options are limited and survival rates are significantly lower.

When lung cancer is detected at stage I, the five-year survival rate is approximately 57%. By stage IV, this drops to around 3%. This stark difference underscores the critical importance of early detection through screening.

Low-dose CT screening has been shown to reduce lung cancer mortality by up to 20% in high-risk populations. Our MRI screening packages include chest imaging that can identify suspicious nodules and other abnormalities requiring further investigation.

Advances in diagnostic technology are improving outcomes. Robotic bronchoscopy, for example, allows physicians to reach and biopsy peripheral lung nodules that were previously inaccessible. This minimally invasive technique improves diagnostic accuracy and enables earlier, more targeted treatment.

Current and former smokers, those with a family history of lung cancer, and individuals with occupational exposure to carcinogens are at highest risk. However, approximately 10 to 15 percent of lung cancers occur in people who have never smoked, making screening valuable for a broad population.

Early detection saves lives. Take the first step today.

View Screening Packages
020 7589 8965Book Now